HIV/AIDS Clinical Trials

Showing 561-580 of 3,256 trials

Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV Viruses

NCT06338826

The main objective of this study is to evaluate at 96 weeks the safety with respect to hepatitis B control of 2 treatment reduction strategies for patients with previously controlled HIV-HBV co-infection on continuous triple therapy

HIV InfectionsHBV Coinfection

ANRS, Emerging Infectious Diseases140 participantsStarted Feb 2025

RECRUITINGPhase 3

Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS

NCT05814432

Phase III trial evaluating the safety and efficacy of a single high dose (10 mg/kg) of liposomal amphotericin B for disseminated histoplasmosis in AIDS patients, in comparison to standard therapy (3 mg/kg of liposomal amphotericin B for two weeks) (INDUCTION trial).

Disseminated Histoplasma Capsulatum InfectionAIDS and InfectionsImmunosuppression+1 more

Federal University of Health Science of Porto Alegre279 participantsStarted Jan 2025

Goiânia, Goiás, Brazil • Natal, Rio Grande do Norte, Brazil • Porto Alegre, Rio Grande do Sul, Brazil +2 more locations

Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV Viruses

Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS

Related Searches

Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected Adults

PrEPared to Choose (PtC) is an Implementation Study of the Delivery of Cabotegravir Long-acting, an Injectable Pre-exposure Prophylaxis (PrEP) Option for HIV Prevention. Injectable PrEP Will be Offered Alongside Oral and Vaginal Ring PrEP From Within a Real-world Context in Cape Town, South Africa.

Feasibility of Positive Links for Youth Care Engagement Intervention

Safety and Immunogenicity of HIV DNA-C CN54ENV and Recombinant HIV CN54gp140 Vaccines in Healthy Volunteers

Home-based Self-sampling for Cervical Cancer Prevention Education Intervention in Ghana

An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ Subjects

Aging With HIV and Neurocognitive Decline, a Follow-up Study

Outcome at 5 Years of Early Treated HIV Infected Infants in the PEDIACAM Project

HIV and Changes in the Gut Microbiome After Changes in Antiretroviral Therapy (ART)

Islatravir and Methadone Pharmacokinetics (MK-8591-029)

Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

SYV: A Mental Health Intervention to Improve HIV Outcomes in Tanzanian Youth

Peer Delivered HIV/Syphilis Self-Testing With Assisted Partner Notification Services

COVID-19 Serology in People Living with HIV in Hong Kong

Prevent TB: Choice Architecture for TPT Delivery

HIV-1, Insufficient Sleep and Vascular Endothelial Dysfunction

Improving HIV Prevention Among Adolescent Girls and Young Women (AGYW) in Uganda

Improving Treatment and Retention Adherence in Nontraditional Settings